# Amgen Inc. (AMGN): SI in SEC Filings | SI Exposure > Amgen Inc. (AMGN): 28.6% of its 10-K, 10-Q and 8-K filings in Q4 2025 to Q3 2026 contain "artificial intelligence"; it has not written "super intelligence" yet. Source: https://tsio.si/exposure/amgn/ Updated: 2026-11-11 Publisher: The SI Observatory (tsio.si), run by the SI community, built by Codeflex 1. [Home](https://tsio.si/) 2. [SI Exposure](https://tsio.si/exposure/) 3. Amgen Inc. (AMGN) SI Exposure · Rank 41 of 100 · Health Care # Amgen Inc. (AMGN) and SI **4 of Amgen Inc.'s 14 10-K, 10-Q and 8-K filings in the last four full quarters (Q4 2025 to Q3 2026) contain "artificial intelligence" or the new name: 28.6%, rank 41 of the 100 largest US companies.** It has not used the new name, "super intelligence" or "superintelligence", in any SEC filing so far. Counts come from SEC EDGAR full text search, Nov 11, 2026. Updated **Nov 11, 2026** · SEC CIK [318154](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000318154) · Sector **Health Care** By quarter [The full ranking](https://tsio.si/exposure/#ranking) [Share on X](https://x.com/intent/post?text=Amgen+Inc.+and+SI%3A+28.6%25+of+its+10-K%2C+10-Q+and+8-K+filings+now+contain+the+phrase%2C+rank+41+of+100.+From+SEC+EDGAR%3A&url=https%3A%2F%2Ftsio.si%2Fexposure%2Famgn%2F) - **Share, last 4 quarters**: 28.6% - **Filings with the phrase**: 4 - **New name, all time**: 0 - **Rank of 100**: 41 Over time ## Amgen Inc. filings, quarter by quarter Since Q1 2023: how many 10-K, 10-Q and 8-K filings Amgen Inc. made each quarter and how many contain "artificial intelligence" or "super intelligence" or "superintelligence". *Chart: Share of Amgen Inc. 10-K, 10-Q and 8-K filings that contain either name. Per calendar quarter; Q4 2026 runs to Nov 11, 2026.* | Quarter | Filings | Old name | New name | Share | |---|---|---|---|---| | Q4 2026 | 3 | 0 | 0 | 0.0% | | Q3 2026 | 3 | 1 | 0 | 33.3% | | Q2 2026 | 5 | 2 | 0 | 40.0% | | Q1 2026 | 4 | 1 | 0 | 25.0% | | Q4 2025 | 2 | 0 | 0 | 0.0% | | Q3 2025 | 2 | 0 | 0 | 0.0% | | Q2 2025 | 3 | 1 | 0 | 33.3% | | Q1 2025 | 2 | 1 | 0 | 50.0% | | Q4 2024 | 2 | 1 | 0 | 50.0% | | Q3 2024 | 2 | 1 | 0 | 50.0% | | Q2 2024 | 3 | 1 | 0 | 33.3% | | Q1 2024 | 2 | 1 | 0 | 50.0% | | Q4 2023 | 5 | 1 | 0 | 20.0% | | Q3 2023 | 6 | 0 | 0 | 0.0% | | Q2 2023 | 6 | 0 | 0 | 0.0% | | Q1 2023 | 5 | 0 | 0 | 0.0% | 10-K, 10-Q and 8-K filings by calendar quarter. Old name: filings with "artificial intelligence". New name: filings with "super intelligence" or "superintelligence". A filing with both counts once in the share. ## Filings with the new name None yet. When Amgen Inc. first files a document with "super intelligence" or "superintelligence", it appears here with a link. ## Latest filings with "artificial intelligence" 1. Aug 5, 2026 [10-Q](https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm) 0000318154-26-000126 2. May 1, 2026 [10-Q](https://www.sec.gov/Archives/edgar/data/318154/000031815426000057/amgn-20260331.htm) 0000318154-26-000057 3. Apr 22, 2026 [8-K](https://www.sec.gov/Archives/edgar/data/318154/000031815426000048/amgn-ex99_1.htm) 0000318154-26-000048 4. Feb 13, 2026 [10-K](https://www.sec.gov/Archives/edgar/data/318154/000031815426000010/amgn-20251231.htm) 0000318154-26-000010 5. May 2, 2025 [10-Q](https://www.sec.gov/Archives/edgar/data/318154/000031815425000020/amgn-20250331.htm) 0000318154-25-000020 6. Feb 14, 2025 [10-K](https://www.sec.gov/Archives/edgar/data/318154/000031815425000010/amgn-20241231.htm) 0000318154-25-000010 7. Oct 31, 2024 [10-Q](https://www.sec.gov/Archives/edgar/data/318154/000031815424000044/amgn-20240930.htm) 0000318154-24-000044 8. Aug 7, 2024 [10-Q](https://www.sec.gov/Archives/edgar/data/318154/000031815424000035/amgn-20240630.htm) 0000318154-24-000035 9. May 3, 2024 [10-Q](https://www.sec.gov/Archives/edgar/data/318154/000031815424000020/amgn-20240331.htm) 0000318154-24-000020 10. Feb 14, 2024 [10-K](https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm) 0000318154-24-000011 11. Dec 14, 2023 [8-K](https://www.sec.gov/Archives/edgar/data/318154/000119312523295027/d598661d8k.htm) 0001193125-23-295027 Embed ## Put this card on any page A plain image that links back here: no script, no cookies. It shows the latest build's numbers and its source. Free to use under CC BY 4.0. Copy the embed ``` SI Exposure of Amgen Inc.: 28.6% of its 10-K, 10-Q and 8-K filings contain "artificial intelligence" ``` ![SI Exposure card for Amgen Inc.](https://tsio.si/exposure/amgn/card.svg) Compare ## Neighbors in the ranking and sector peers [Rank 39 · Finance**Wells Fargo & Company**28.6% of filings · 0 with the new name](https://tsio.si/exposure/wfc/) [Rank 40 · Industrials**Caterpillar Inc.**28.6% of filings · 0 with the new name](https://tsio.si/exposure/cat/) [Rank 42 · Health Care**Intuitive Surgical Inc.**28.6% of filings · 0 with the new name](https://tsio.si/exposure/isrg/) [Rank 43 · Health Care**Medtronic plc.**28.6% of filings · 0 with the new name](https://tsio.si/exposure/mdt/) [Rank 5 · Health Care**Eli Lilly and Company**72.7% of filings · 0 with the new name](https://tsio.si/exposure/lly/) [Rank 7 · Health Care**Pfizer Inc.**71.4% of filings · 0 with the new name](https://tsio.si/exposure/pfe/)